Replies to post #291031 on Anavex Life Sciences Corp (AVXL)

[Gernee20]

Boi, agree. Also, it appears he has gotten the go ahead from the fda to jump into these rare diseases with pivotal ph2/3’s. HUGE. It’s also a method of getting more IP protection with each rare disease approval.

I’m guessing in the coming months we will be granted ODD for 2-73 in Fragile X and the new, unnamed rare disease indication, as well.